##gff-version 3
##sequence-region O95278 1 331
O95278	UniProtKB	Chain	1	331	.	.	.	ID=PRO_0000094838;Note=Laforin	
O95278	UniProtKB	Domain	1	124	.	.	.	Note=CBM20;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00594	
O95278	UniProtKB	Domain	243	311	.	.	.	Note=Tyrosine-protein phosphatase	
O95278	UniProtKB	Region	103	107	.	.	.	Note=Substrate binding;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:4RKK,ECO:0000269|PubMed:25544560;Dbxref=PMID:25544560	
O95278	UniProtKB	Region	267	272	.	.	.	Note=Substrate binding;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:4RKK,ECO:0000269|PubMed:25544560;Dbxref=PMID:25544560	
O95278	UniProtKB	Motif	266	272	.	.	.	Note=Glucan phosphatase signature motif CXAGXGR;Ontology_term=ECO:0000305,ECO:0000305;evidence=ECO:0000305|PubMed:25544560,ECO:0000305|PubMed:26231210;Dbxref=PMID:25544560,PMID:26231210	
O95278	UniProtKB	Active site	266	266	.	.	.	Note=Phosphocysteine intermediate;Ontology_term=ECO:0000255,ECO:0000305,ECO:0000305,ECO:0000305,ECO:0000305,ECO:0000305,ECO:0000305;evidence=ECO:0000255|PROSITE-ProRule:PRU10044,ECO:0000305|PubMed:11220751,ECO:0000305|PubMed:11739371,ECO:0000305|PubMed:14532330,ECO:0000305|PubMed:22036712,ECO:0000305|PubMed:25538239,ECO:0000305|PubMed:25544560;Dbxref=PMID:11220751,PMID:11739371,PMID:14532330,PMID:22036712,PMID:25538239,PMID:25544560	
O95278	UniProtKB	Binding site	32	32	.	.	.	Note=Substrate;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:4RKK,ECO:0000269|PubMed:25544560;Dbxref=PMID:25544560	
O95278	UniProtKB	Binding site	87	87	.	.	.	Note=Substrate;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:4RKK,ECO:0000269|PubMed:25544560;Dbxref=PMID:25544560	
O95278	UniProtKB	Binding site	197	197	.	.	.	Note=Substrate;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:4RKK,ECO:0000269|PubMed:25544560;Dbxref=PMID:25544560	
O95278	UniProtKB	Binding site	235	235	.	.	.	Note=Substrate;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:4RKK,ECO:0000269|PubMed:25544560;Dbxref=PMID:25544560	
O95278	UniProtKB	Binding site	241	241	.	.	.	Note=Substrate;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:4RKK,ECO:0000269|PubMed:25544560;Dbxref=PMID:25544560	
O95278	UniProtKB	Binding site	304	304	.	.	.	Note=Substrate;Ontology_term=ECO:0000244,ECO:0000269;evidence=ECO:0000244|PDB:4RKK,ECO:0000269|PubMed:25544560;Dbxref=PMID:25544560	
O95278	UniProtKB	Site	329	329	.	.	.	Note=Required for homodimerization;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23922729;Dbxref=PMID:23922729	
O95278	UniProtKB	Modified residue	25	25	.	.	.	Note=Phosphoserine%3B by AMPK;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21728993;Dbxref=PMID:21728993	
O95278	UniProtKB	Alternative sequence	1	243	.	.	.	ID=VSP_042494;Note=In isoform 6. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
O95278	UniProtKB	Alternative sequence	1	159	.	.	.	ID=VSP_042495;Note=In isoform 7. MRFRFGVVVPPAVAGARPELLVVGSRPELGRWEPRGAVRLRPAGTAAGDGALALQEPGLWLGEVELAAEEAAQDGAEPGRVDTFWYKFLKREPGGELSWEGNGPHHDRCCTYNENNLVDGVYCLPIGHWIEATGHTNEMKHTTDFYFNIAGHQAMHYSR->MIFNK;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
O95278	UniProtKB	Alternative sequence	1	138	.	.	.	ID=VSP_042493;Note=In isoform 8. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:14702039,ECO:0000303|Ref.4;Dbxref=PMID:14702039	
O95278	UniProtKB	Alternative sequence	102	199	.	.	.	ID=VSP_011015;Note=In isoform 4. NGPHHDRCCTYNENNLVDGVYCLPIGHWIEATGHTNEMKHTTDFYFNIAGHQAMHYSRILPNIWLGSCPRQVEHVTIKLKHELGITAVMNFQTEWDIV->IASRRLPPAQSGSSGPHPQPGPRPRAGPAGPGGARPGLFARVPAHSPGDLG;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.4	
O95278	UniProtKB	Alternative sequence	160	293	.	.	.	ID=VSP_042496;Note=In isoform 5. Missing;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O95278	UniProtKB	Alternative sequence	200	331	.	.	.	ID=VSP_011016;Note=In isoform 4. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.4	
O95278	UniProtKB	Alternative sequence	294	331	.	.	.	ID=VSP_042497;Note=In isoform 5. YFLMAKRPAVYIDEEALARAQEDFFQKFGKVRSSVCSL->PSTDAAPGGVPAACAAGEGTHRVRALQRWGGPLHRGCLRLAPVCDGLESEEGAVFPHGQEAGCLH;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O95278	UniProtKB	Alternative sequence	310	320	.	.	.	ID=VSP_011017;Note=In isoform 2. LARAQEDFFQK->ASQDTFPL;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:9771710,ECO:0000303|PubMed:9931343;Dbxref=PMID:9771710,PMID:9931343	
O95278	UniProtKB	Alternative sequence	321	331	.	.	.	ID=VSP_011018;Note=In isoform 2. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:9771710,ECO:0000303|PubMed:9931343;Dbxref=PMID:9771710,PMID:9931343	
O95278	UniProtKB	Natural variant	25	25	.	.	.	ID=VAR_019465;Note=In EPM2%3B atypical form%3B does not affect glycogen binding. S->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12019207,ECO:0000269|PubMed:14706656;Dbxref=PMID:12019207,PMID:14706656	
O95278	UniProtKB	Natural variant	28	28	.	.	.	ID=VAR_019466;Note=In EPM2%3B does not affect glycogen binding. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14706656;Dbxref=PMID:14706656	
O95278	UniProtKB	Natural variant	32	32	.	.	.	ID=VAR_019467;Note=In EPM2%3B impairs protein stability%3B affects phosphatase activity%3B abolishes glycogen binding%3B abolishes phosphatase activity with insoluble glucan%3B disrupts the interaction with PPP1R3C. W->G;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11739371,ECO:0000269|PubMed:12019207,ECO:0000269|PubMed:14532330,ECO:0000269|PubMed:14706656,ECO:0000269|PubMed:25544560,ECO:0000269|PubMed:26231210;Dbxref=dbSNP:rs104893955,PMID:11739371,PMID:12019207,PMID:14532330,PMID:14706656,PMID:25544560,PMID:26231210	
O95278	UniProtKB	Natural variant	46	46	.	.	.	ID=VAR_019468;Note=Does not affect glycogen binding. A->P;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11735300,ECO:0000269|PubMed:14706656,ECO:0000269|PubMed:16021330;Dbxref=dbSNP:rs374338349,PMID:11735300,PMID:14706656,PMID:16021330	
O95278	UniProtKB	Natural variant	84	84	.	.	.	ID=VAR_019469;Note=In EPM2%3B affects phosphatase activity and glycogen binding%3B disrupts the interaction with PPP1R3C. F->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11175283,ECO:0000269|PubMed:14532330;Dbxref=dbSNP:rs1362231306,PMID:11175283,PMID:14532330	
O95278	UniProtKB	Natural variant	88	88	.	.	.	ID=VAR_019470;Note=In EPM2%3B does not affect glycogen binding. F->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:14706656;Dbxref=dbSNP:rs1034706422,dbSNP:rs1463000703,PMID:14706656	
O95278	UniProtKB	Natural variant	91	91	.	.	.	ID=VAR_019471;Note=In EPM2%3B atypical form%3B learning difficuties with childhood-onset. R->P;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14722920,ECO:0000269|PubMed:15009235;Dbxref=PMID:14722920,PMID:15009235	
O95278	UniProtKB	Natural variant	108	108	.	.	.	ID=VAR_019472;Note=In EPM2%3B loss of phosphatase activity%3B reduced self-interaction capacity%3B disrupts the interaction with PPP1R3C. R->C;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12019207,ECO:0000269|PubMed:14532330,ECO:0000269|PubMed:9771710;Dbxref=dbSNP:rs137852915,PMID:12019207,PMID:14532330,PMID:9771710	
O95278	UniProtKB	Natural variant	114	114	.	.	.	ID=VAR_019473;Note=E->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9771710;Dbxref=PMID:9771710	
O95278	UniProtKB	Natural variant	140	140	.	.	.	ID=VAR_046383;Note=In EPM2. K->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18311786;Dbxref=PMID:18311786	
O95278	UniProtKB	Natural variant	148	148	.	.	.	ID=VAR_046384;Note=In EPM2. N->Y;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18311786;Dbxref=PMID:18311786	
O95278	UniProtKB	Natural variant	171	171	.	.	.	ID=VAR_019474;Note=In EPM2%3B results in ubiquitin-positive perinuclear aggregates%3B no effect on glycogen binding%3B abolishes phosphatase activity%3B may affect proper folding. R->H;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11001928,ECO:0000269|PubMed:12019207,ECO:0000269|PubMed:14722920,ECO:0000269|PubMed:25544560,ECO:0000269|PubMed:9931343;Dbxref=dbSNP:rs137852916,PMID:11001928,PMID:12019207,PMID:14722920,PMID:25544560,PMID:9931343	
O95278	UniProtKB	Natural variant	187	187	.	.	.	ID=VAR_019475;Note=In EPM2%3B abolishes interaction with NHLRC1. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12560877;Dbxref=PMID:12560877	
O95278	UniProtKB	Natural variant	194	194	.	.	.	ID=VAR_019476;Note=In EPM2%3B results in ubiquitin-positive perinuclear aggregates%3B loss of phosphatase activity%3B affects glycogen binding%3B reduced self-interaction capacity%3B abolishes interaction with NHLRC1%2C PPP1R3C and PRKAA2%3B no effect on phosphorylation of protein. T->I;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12019207,ECO:0000269|PubMed:14532330,ECO:0000269|PubMed:9931343;Dbxref=dbSNP:rs375544596,PMID:12019207,PMID:14532330,PMID:9931343	
O95278	UniProtKB	Natural variant	210	210	.	.	.	ID=VAR_046385;Note=In EPM2. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18311786;Dbxref=PMID:18311786	
O95278	UniProtKB	Natural variant	240	240	.	.	.	ID=VAR_019477;Note=In EPM2%3B impaired phosphatase activity%3B does not affect glycogen binding%3B disrupts the interaction with PPP1R3C. G->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11175283,ECO:0000269|PubMed:14532330,ECO:0000269|PubMed:25544560;Dbxref=PMID:11175283,PMID:14532330,PMID:25544560	
O95278	UniProtKB	Natural variant	279	279	.	.	.	ID=VAR_019478;Note=In EPM2%3B results in ubiquitin-positive perinuclear aggregates%3B loss of phosphatase activity%3B affects glycogen binding%3B disrupts the interaction with PPP1R3C. G->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12019207,ECO:0000269|PubMed:14532330,ECO:0000269|PubMed:14722920,ECO:0000269|PubMed:9771710,ECO:0000269|PubMed:9931343;Dbxref=dbSNP:rs137852917,PMID:12019207,PMID:14532330,PMID:14722920,PMID:9771710,PMID:9931343	
O95278	UniProtKB	Natural variant	293	293	.	.	.	ID=VAR_019479;Note=In EPM2%3B results in ubiquitin-positive perinuclear aggregates%3B may affect proper folding%3B loss of phosphatase activity%3B affects glycogen binding%3B disrupts the interaction with PPP1R3C. Q->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11001928,ECO:0000269|PubMed:12019207,ECO:0000269|PubMed:14532330,ECO:0000269|PubMed:9771710;Dbxref=dbSNP:rs796052427,PMID:11001928,PMID:12019207,PMID:14532330,PMID:9771710	
O95278	UniProtKB	Natural variant	294	294	.	.	.	ID=VAR_019480;Note=In EPM2%3B results in ubiquitin-positive perinuclear aggregates%3B impairs phosphatase activity%3B affects glycogen binding%3B disrupts the interaction with PPP1R3C. Y->N;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:12019207,ECO:0000269|PubMed:14532330,ECO:0000269|PubMed:25544560,ECO:0000269|PubMed:9931343;Dbxref=PMID:12019207,PMID:14532330,PMID:25544560,PMID:9931343	
O95278	UniProtKB	Natural variant	301	301	.	.	.	ID=VAR_019481;Note=In EPM2%3B impairs protein stability%3B impairs phosphatase activity%3B affects glycogen binding%3B disrupts the interaction with PPP1R3C. P->L;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11175283,ECO:0000269|PubMed:14532330,ECO:0000269|PubMed:25544560;Dbxref=dbSNP:rs796052428,PMID:11175283,PMID:14532330,PMID:25544560	
O95278	UniProtKB	Natural variant	310	310	.	.	.	ID=VAR_046386;Note=In EPM2%3B causes location of isoform 1 at cytoplasmic punctae%3B does not affect homodimerization of isoform 1 but prevents heterodimerization of isoform 1 and isoform 2. L->W;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18311786;Dbxref=PMID:18311786	
O95278	UniProtKB	Mutagenesis	8	8	.	.	.	Note=Loss of phosphatase activity. No effect on glycogen binding. V->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25544560;Dbxref=PMID:25544560	
O95278	UniProtKB	Mutagenesis	25	25	.	.	.	Note=Partial loss of phosphatase activity. Abolishes homodimerization. Abolishes interaction with NHLRC1%2C PPP1R3C and PRKAA2. Does not affect glycogen binding. Reduces stability of the protein. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21728993;Dbxref=PMID:21728993	
O95278	UniProtKB	Mutagenesis	25	25	.	.	.	Note=Partial loss of phosphatase activity. Increases interaction with NHLRC1. Does not affect interaction with NHLRC1%2C PPP1R3C or PRKAA2. Does not affect binding to carbohydrate. Does not affect homodimerization. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21728993;Dbxref=PMID:21728993	
O95278	UniProtKB	Mutagenesis	87	87	.	.	.	Note=Loss of phosphatase activity. Abolishes glycogen binding. K->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11739371,ECO:0000269|PubMed:25544560;Dbxref=PMID:11739371,PMID:25544560	
O95278	UniProtKB	Mutagenesis	99	99	.	.	.	Note=Strongly reduces phosphatase activity. Strongly reduces glycogen binding. W->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25544560;Dbxref=PMID:25544560	
O95278	UniProtKB	Mutagenesis	109	110	.	.	.	Note=No effect on homodimerization or carbohydrate binding. Decreased phosphatase activity. CC->SS;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23922729;Dbxref=PMID:23922729	
O95278	UniProtKB	Mutagenesis	123	123	.	.	.	Note=No effect on homodimerization or carbohydrate binding. Decreased phosphatase activity. C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23922729;Dbxref=PMID:23922729	
O95278	UniProtKB	Mutagenesis	126	126	.	.	.	Note=Strongly decreased phosphatase activity. No effect on glycogen binding. I->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25544560;Dbxref=PMID:25544560	
O95278	UniProtKB	Mutagenesis	142	142	.	.	.	Note=Strongly decreased phosphatase activity. No effect on glycogen binding. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25544560;Dbxref=PMID:25544560	
O95278	UniProtKB	Mutagenesis	168	168	.	.	.	Note=Abolishes interaction with NHLRC1. S->A%2CD;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21728993;Dbxref=PMID:21728993	
O95278	UniProtKB	Mutagenesis	169	169	.	.	.	Note=No effect on homodimerization or carbohydrate binding. Decreased phosphatase activity. C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23922729;Dbxref=PMID:23922729	
O95278	UniProtKB	Mutagenesis	169	169	.	.	.	Note=No effect on phosphatase activity. C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25538239;Dbxref=PMID:25538239	
O95278	UniProtKB	Mutagenesis	171	171	.	.	.	Note=No effect on phosphatase activity. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25538239;Dbxref=PMID:25538239	
O95278	UniProtKB	Mutagenesis	187	187	.	.	.	Note=Abolishes interaction with NHLRC1. T->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21728993;Dbxref=PMID:21728993	
O95278	UniProtKB	Mutagenesis	194	194	.	.	.	Note=Does not affect interaction with NHLRC1%2C PPP1R3C or PRKAA2. T->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21728993;Dbxref=PMID:21728993	
O95278	UniProtKB	Mutagenesis	197	197	.	.	.	Note=Strongly decreased phosphatase activity. No effect on glycogen binding. D->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:25538239,ECO:0000269|PubMed:25544560;Dbxref=PMID:25538239,PMID:25544560	
O95278	UniProtKB	Mutagenesis	205	205	.	.	.	Note=No effect on homodimerization or carbohydrate binding. Decreased phosphatase activity. C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23922729;Dbxref=PMID:23922729	
O95278	UniProtKB	Mutagenesis	235	235	.	.	.	Note=Complete loss of phosphatase activity. Does not affect glycogen binding. D->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:14532330,ECO:0000269|PubMed:25538239;Dbxref=PMID:14532330,PMID:25538239	
O95278	UniProtKB	Mutagenesis	236	236	.	.	.	Note=Complete loss of phosphatase activity. No effect on glycogen binding. M->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25544560;Dbxref=PMID:25544560	
O95278	UniProtKB	Mutagenesis	250	250	.	.	.	Note=No effect on homodimerization or carbohydrate binding. Decreased phosphatase activity. C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23922729;Dbxref=PMID:23922729	
O95278	UniProtKB	Mutagenesis	251	251	.	.	.	Note=Impairs protein stability. Strongly reduces phosphatase activity. No effect on glycogen binding. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25544560;Dbxref=PMID:25544560	
O95278	UniProtKB	Mutagenesis	266	266	.	.	.	Note=Complete loss of phosphatase activity. Does not affect glycogen binding. Does not affect self-interaction. Increases the interaction with PPP1R3C. C->S;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11220751,ECO:0000269|PubMed:11739371,ECO:0000269|PubMed:14532330,ECO:0000269|PubMed:22036712,ECO:0000269|PubMed:23922729,ECO:0000269|PubMed:25538239,ECO:0000269|PubMed:25544560;Dbxref=PMID:11220751,PMID:11739371,PMID:14532330,PMID:22036712,PMID:23922729,PMID:25538239,PMID:25544560	
O95278	UniProtKB	Mutagenesis	272	272	.	.	.	Note=Complete loss of phosphatase activity. R->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25538239;Dbxref=PMID:25538239	
O95278	UniProtKB	Mutagenesis	321	321	.	.	.	Note=Impairs protein stability. Strongly reduces phosphatase activity. No effect on glycogen binding. F->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25544560;Dbxref=PMID:25544560	
O95278	UniProtKB	Mutagenesis	329	331	.	.	.	Note=Fails to homodimerize. Does not affect carbohydrate binding or phosphatase activity. Missing;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23922729;Dbxref=PMID:23922729	
O95278	UniProtKB	Mutagenesis	329	329	.	.	.	Note=Fails to homodimerize. Does not affect carbohydrate binding%2C interaction with NHLRC1%2C phosphatase activity%2C or ubiquitination by NHLRC1. C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:23922729;Dbxref=PMID:23922729	
O95278	UniProtKB	Mutagenesis	329	329	.	.	.	Note=No effect on homodimerization. C->S;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:25538239;Dbxref=PMID:25538239	
O95278	UniProtKB	Sequence conflict	193	193	.	.	.	Note=Q->K;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O95278	UniProtKB	Sequence conflict	248	248	.	.	.	Note=A->P;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O95278	UniProtKB	Sequence conflict	258	258	.	.	.	Note=K->E;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O95278	UniProtKB	Sequence conflict	294	294	.	.	.	Note=Y->H;Ontology_term=ECO:0000305;evidence=ECO:0000305	
O95278	UniProtKB	Beta strand	1	9	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4RKK	
O95278	UniProtKB	Helix	11	14	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4RKK	
O95278	UniProtKB	Beta strand	19	26	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4RKK	
O95278	UniProtKB	Helix	27	29	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4RKK	
O95278	UniProtKB	Turn	30	32	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4RKK	
O95278	UniProtKB	Helix	34	36	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4RKK	
O95278	UniProtKB	Beta strand	58	67	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4RKK	
O95278	UniProtKB	Beta strand	84	91	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4RKK	
O95278	UniProtKB	Beta strand	97	103	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4RKK	
O95278	UniProtKB	Helix	104	106	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4RKK	
O95278	UniProtKB	Beta strand	108	110	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4RKK	
O95278	UniProtKB	Helix	114	116	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4RKK	
O95278	UniProtKB	Beta strand	121	123	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4RKK	
O95278	UniProtKB	Helix	138	151	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4RKK	
O95278	UniProtKB	Beta strand	157	161	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4R30	
O95278	UniProtKB	Beta strand	164	167	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4R30	
O95278	UniProtKB	Helix	173	177	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4R30	
O95278	UniProtKB	Helix	178	183	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4R30	
O95278	UniProtKB	Beta strand	188	191	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4R30	
O95278	UniProtKB	Helix	195	201	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4R30	
O95278	UniProtKB	Helix	203	205	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4R30	
O95278	UniProtKB	Beta strand	208	210	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4R30	
O95278	UniProtKB	Helix	214	223	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4R30	
O95278	UniProtKB	Beta strand	227	230	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4R30	
O95278	UniProtKB	Helix	238	258	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4R30	
O95278	UniProtKB	Beta strand	262	265	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4R30	
O95278	UniProtKB	Helix	271	283	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4R30	
O95278	UniProtKB	Helix	289	296	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4R30	
O95278	UniProtKB	Beta strand	303	305	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4R30	
O95278	UniProtKB	Helix	307	321	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4R30	
